Paris, France and Camberley, UK – 1 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). http://novacyt.com/wp-content/uploads/2019/07/Liquidity-Agreement-1-July-2019.pdf
Visit PageNews and Events
Liquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 1 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised
Visit PageConversion d’OCABSA
Paris, France et Camberley, UK – 28 juin 2019 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT) annonce qu’en vertu du programme de financement par des Obligations Convertibles assorties de warrants annoncé le 23 avril 2019, elle a émis une tranche d’actions ordinaires nouvelles de 1/15ème d’euro chacune (« Actions Ordinaires ») à
Visit Page